Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
How often are adverse events in heart failure patients actually attributable to guideline-directed medical therapies, as opposed to a manifestation of HFrEF itself or other comorbidities?
A new study adds to the evidence that NT-proBNP levels are strong prognostic markers of clinical severity in patients with HFpEF, and may inform potential for treatment response to SGLT2 inhibitors.
Mission Statement:
Aligned with the ACC's mission to transform cardiovascular care and improve heart health, the JACC Journals continuously strive to provide the best resources for cardiovascular investigators, clinicians, and specialists at every professional stage.